The latest and perhaps final summary of HIV.gov insights from CROI 2024 focuses on Doxy-PEP (prevention of STIs) and long-acting antiretroviral therapies (for prevention and care). Watch the conversation between CDC's Dr. Jonathan Mermin and Miguel Gomez, Director of HIV.gov.
Watch and read more from HIV.gov on CROI and access our resources on long-acting ART and STIs.